Published TCIMAIL newest issue No.200
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 251456-60-7 | Product Number: D4188
4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
Purity: >97.0%(HPLC)
Synonyms:
- M 344
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 20MG |
€119.00
|
1 | 20 |
|
|
| 100MG |
€414.00
|
Contact Us | 7 |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | D4188 |
Purity / Analysis Method
|
>97.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__2__5N__3O__3 = 307.39 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
Packaging and Container
|
20MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 251456-60-7 |
| Reaxys Registry Number | 8570090 |
| PubChem Substance ID | 160871269 |
| MDL Number | MFCD03453554 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Elemental analysis(Nitrogen) | 13.20 to 13.80 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 152 °C |
GHS
Related Laws:
Transport Information:
| HS Number | 2928009090 |
Application
M344: A Histone Deacetylase (HDAC) Inhibitor
Histone deacetylase (HDAC) inhibitors are emerging therapeutic agents with potential for disruption of critical cellular processes in cancer cells. M344 is a synthesized HDAC inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in cancer cells. (The product is for research purpose only.)
References
- Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
- Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation
- The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells
- M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells
- Histone deacetylase inhibitor M344 inhibits cell proliferation and induces apoptosis in human THP-1 leukemia cells
- Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.